A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats.
about
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in miceMesenchymal stem cell-derived molecules reverse fulminant hepatic failureInterleukin-1 receptor antagonist modulates the early phase of liver regeneration after partial hepatectomy in mice.Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure.Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failureProliferative human cell sources applied as biocomponent in bioartificial livers: a review.Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B.Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.Therapeutic evaluation of a microbioartificial liver with recombinant HepG2 cells for rats with hepatic failure.Interleukin-1α and Interleukin-1β play a central role in the pathogenesis of fulminant hepatic failure in mice.Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice.Nucleos(t)ide analogs improve long-term prognosis in patients with chronic hepatitis B-associated liver failure.
P2860
Q27008536-3A7CD7ED-16C1-4807-A51E-6C0E476AF5ADQ33300346-3EF128B1-3099-447C-8B0B-F440E910C68AQ34043198-2C25E7BD-6EC0-4DA1-94A7-5D36FA6F3D51Q35826421-90630217-A30C-4BF1-8BBE-3D5EA533AA9DQ37250336-E3CF1D8C-383D-4EE3-B29A-6F444F636AF6Q37471408-E94BF042-86E2-4A07-8834-96B057EDC17CQ38014905-E308D07A-72F0-4BFC-883A-8BC3F97688EAQ38752436-4F0EF787-B3BC-47AB-B1E0-21A10AD9EB3BQ38858897-F1022EB4-DDA0-4804-82AE-788437C70ABDQ39090591-C266ADDF-5A84-427B-BA14-F3B029319995Q42236556-3EBD3C76-034D-4512-9479-EBE4C6170FC9Q42586870-ED029A6F-2104-4BC8-9946-344FA310366AQ48206114-FEAED442-FEC0-4588-9E0F-578A04FD9730
P2860
A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A bioartificial liver device s ...... nt of hepatic failure in rats.
@ast
A bioartificial liver device s ...... nt of hepatic failure in rats.
@en
type
label
A bioartificial liver device s ...... nt of hepatic failure in rats.
@ast
A bioartificial liver device s ...... nt of hepatic failure in rats.
@en
prefLabel
A bioartificial liver device s ...... nt of hepatic failure in rats.
@ast
A bioartificial liver device s ...... nt of hepatic failure in rats.
@en
P2093
P2860
P1476
A bioartificial liver device s ...... nt of hepatic failure in rats.
@en
P2093
Arno W Tilles
Atsushi Takayanagi
François Berthiaume
Go Wakabayashi
Hideaki Obara
Hirohisa Harada
Kazuhiro Suganuma
Martin L Yarmush
Masahiro Shinoda
Masaki Kitajima
P2860
P304
P356
10.1016/J.JSS.2006.08.009
P50
P577
2006-11-01T00:00:00Z